製品の概要

  • 製品名
    Anti-MARK 1+2+3+4 antibody
  • 製品の詳細
    Rabbit polyclonal to MARK 1+2+3+4
  • 特異性
    ab74131 detects endogenous levels of total MARK 1+2+3+4 protein.
  • アプリケーション
    適用あり: WB, ELISA, IHC-P, ICC/IFmore details
  • 種交差性
    交差種: Mouse, Human
    交差が予測される動物種: Rat
  • 免疫原

    Synthetic non-phosphopeptide derived from human MARK1/2/3/4 around the phosphorylation site of threonine 215 (L-D-TP-F-C).

  • ポジティブ・コントロール
    • Human breast carcinoma tissue. Extracts from COS-7 cells. HeLa cells.

製品の特性

アプリケーション

Our Abpromise guarantee covers the use of ab74131 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

アプリケーション Abreviews 特記事項
WB 1/500 - 1/1000. Predicted molecular weight: 89 kDa.
ELISA 1/5000.
IHC-P 1/50 - 1/100.
ICC/IF 1/100 - 1/500.

ターゲット情報

画像

  • All lanes : Anti-MARK 1+2+3+4 antibody (ab74131) at 1/500 dilution

    Lane 1 : Extracts from COS-7 cells
    Lane 2 : Extracts from COS-7 cells with immunising peptide at 5 µg

    Lysates/proteins at 5 µg per lane.


    Predicted band size : 89 kDa
    Observed band size : 89 kDa
  • Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue using ab74131, at 1/50 dilution, in the presence (right panel) or absence (left panel) of immunising peptide.
  • Immunofluorescence analysis of HeLa cells, using ab74131 at 1/100 dilution, in the presence (right panel) or absence (left panel) of immunising peptide.

参考文献

This product has been referenced in:
  • Mian I  et al. LKB1 destabilizes microtubules in myoblasts and contributes to myoblast differentiation. PLoS One 7:e31583 (2012). WB ; Mouse . Read more (PubMed: 22348111) »

See 1 Publication for this product

レビューと Q&A

There are currently no Customer reviews or Questions for ab74131.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

登録